# James E. Udelson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-e-udelson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,201 |
| Field | Cardiac Imaging and Diagnostics |
| h-index | 103 |
| i10-index | 281 |
| Last Known Institution | Tufts Medical Center |
| OpenAlex ID | https://openalex.org/A5080222829 |
| ORCID iD | https://orcid.org/0000-0003-2998-910X |
| Works | 548 |

## Researcher papers

Showing 12 of 15.

- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic-2/)
- [Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease](https://scholariq.org/papers/outcomes-of-anatomical-versus-functional-testing-for-coronary-artery-disease/)
- [ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary](https://scholariq.org/papers/acc-aha-asnc-guidelines-for-the-clinical-use-of-cardiac-radionuclide-imaging/)
- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic/)
- [Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy](https://scholariq.org/papers/prognostic-value-of-quantitative-contrast-enhanced-cardiovascular-magnetic/)
- [2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary](https://scholariq.org/papers/2011-accf-aha-guideline-for-the-diagnosis-and-treatment-of-hypertrophic-3/)
- [ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary](https://scholariq.org/papers/acc-aha-asnc-guidelines-for-the-clinical-use-of-cardiac-radionuclide-imaging-2/)
- [Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2](https://scholariq.org/papers/pharmacological-treatment-of-coronary-artery-disease-with-recombinant-fibroblast/)
- [Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure](https://scholariq.org/papers/double-blind-placebo-controlled-study-of-the-effects-of-carvedilol-in-patients/)
- [Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial](https://scholariq.org/papers/clinical-course-and-predictive-value-of-congestion-during-hospitalization-in/)
- [Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus](https://scholariq.org/papers/clinical-trials-in-coronary-angiogenesis-issues-problems-consensus/)
- [Cardiovascular Function and Treatment in β-Thalassemia Major](https://scholariq.org/papers/cardiovascular-function-and-treatment-in-thalassemia-major/)

## Researcher topics

- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)

## Researcher university

- [Tufts Medical Center](https://scholariq.org/institutions/tufts-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.